United States, Dec. 1 -- GE HealthCare announced the 510(k) submissions to the U.S. Food and Drug Administration (FDA) seeking clearance for next-generation SIGNA (TM) MRI technology. Unveiled at the Radiological Society of North America's 2025 Annual Meeting, these differentiated solutions are part of a wave of new GE HealthCare innovations aimed at tackling some of the most complex challenges in healthcare. Designed to enhance precision diagnosis for clinicians and help clinicians improve patient outcomes, the new technologies include GE HealthCare's 1.5T MRI system, both equipped with an AI-powered workflow platform designed for end-to-end exam efficiency.With imaging needs outpacing the radiologist workforce, leading to longer wait time...